Boundless Bio

United States
San Diego, California, United States, 92037

Company profile

Boundless Bio company profile

Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat untraceable cancers. It aims to be the biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.

Business identity

Contact email
[email protected]
Phone number
858-766-9912
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2018-01-01, Year

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$251.4M
Last funding
Series C / $100M / 2023-05-16
Last equity funding
Series C / $100M
Investors
18
Lead investors
5
Founders
4
Articles
124
Exited on
2024-03-28

Founders and investors

Founders

Benjamin CravattHoward ChangJonathan LimKeith Lenden

Lead investors

ARCH Venture PartnersCity Hill VenturesLeaps by BayerNextech InvestRA Capital Management

Investors

ARCH Venture PartnersFidelityRA Capital ManagementVertex VenturesWellington Management